Intervention Protocol

Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND)

  1. Carolyn A Young1,*,
  2. Chris Gibbons2,
  3. Francesco Pagnini3,
  4. Tim Friede4

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 2 MAR 2014

DOI: 10.1002/14651858.CD011005


How to Cite

Young CA, Gibbons C, Pagnini F, Friede T. Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011005. DOI: 10.1002/14651858.CD011005.

Author Information

  1. 1

    The Walton Centre for Neurology and Neurosurgery, Liverpool, UK

  2. 2

    University of Manchester, Collaboration for Leadership in Applied Health Research and Care (CLAHRC), Manchester, UK

  3. 3

    Catholic University of Milan, Department of Psychology, Milano, Italy

  4. 4

    Universitätsmedizin Göttingen, Institut für Medizinische Statistik, Göttingen, Germany

*Carolyn A Young, The Walton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK. Carolyn.Young@thewaltoncentre.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 2 MAR 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of pharmacological and non-pharmacological interventions for fatigue in ALS/MND.